MWVC
Morgens Waterfall Vintiadis & Co Portfolio holdings
AUM
$136M
This Quarter Return
-1.33%
1 Year Return
+103.3%
3 Year Return
+567.71%
5 Year Return
+1,003.82%
10 Year Return
+9,424.15%
AUM
$130M
AUM Growth
+$130M
(-10%)
Cap. Flow
-$10.4M
Cap. Flow
% of AUM
-7.99%
Top 10 Holdings %
Top 10 Hldgs %
39.07%
Holding
62
New
8
Increased
15
Reduced
9
Closed
11
Top Buys
| 1 |
Take-Two Interactive
TTWO
|
$4.76M |
| 2 |
Advanced Micro Devices
AMD
|
$3.35M |
| 3 |
Shopify
SHOP
|
$3.12M |
| 4 |
American Tower
AMT
|
$3.1M |
| 5 |
Wynn Resorts
WYNN
|
$2.77M |
Top Sells
| 1 |
NEWR
New Relic, Inc.
NEWR
|
$4.97M |
| 2 |
WORK
Slack Technologies, Inc.
WORK
|
$3.39M |
| 3 |
Boyd Gaming
BYD
|
$3.23M |
| 4 |
Caesars Entertainment
CZR
|
$3.23M |
| 5 |
Boeing
BA
|
$3.05M |
Sector Composition
| 1 | Technology | 36.09% |
| 2 | Consumer Discretionary | 25.73% |
| 3 | Healthcare | 12.83% |
| 4 | Communication Services | 10.95% |
| 5 | Financials | 5.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
ADMA Biologics
ADMA
$4.12B
| $2.45M | 1.88% | 550,000 | – | – |
|
27
eHealth
EHTH
$118M
| $2.34M | 1.8% | 35,000 +5,000 | +17% | +$334K |
|
28
Visa
V
$683B
| $2.22M | 1.7% | 12,900 +2,900 | +29% | +$499K |
|
29
Mastercard
MA
$538B
| $1.77M | 1.36% | 6,500 | – | – |
|
30
Medtronic
MDT
$119B
| $1.63M | 1.25% | 15,000 | – | – |
|
31
Illumina
ILMN
$15.8B
| $1.52M | 1.17% | 5,000 | – | – |
|
32
Thermo Fisher Scientific
TMO
$186B
| $1.46M | 1.12% | +5,000 | New | +$1.46M |
|
33
Incyte
INCY
$16.5B
| $1.34M | 1.03% | 18,000 +6,000 | +50% | +$445K |
|
34
UnitedHealth
UNH
$281B
| $1.17M | 0.9% | 5,400 | – | – |
|
35
VICI Properties
VICI
$36B
| $1.12M | 0.86% | +49,230 | New | +$1.12M |
|
|
TRHC
36
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $1.1M | 0.84% | 20,000 | – | – |
|
|
MGP
37
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $969K | 0.74% | 32,250 +15,000 | +87% | +$451K |
|
38
Labcorp
LH
$23.1B
| $941K | 0.72% | 5,600 | – | – |
|
39
Heron Therapeutics
HRTX
$207M
| $722K | 0.55% | 39,000 | – | – |
|
40
AstraZeneca
AZN
$248B
| $575K | 0.44% | 12,900 | – | – |
|
|
41
Boeing
BA
$177B
| $571K | 0.44% | 1,500 -8,000 | -84% | -$3.05M |
|
42
JPMorgan Chase
JPM
$829B
| $538K | 0.41% | 4,575 | – | – |
|
43
Merck
MRK
$210B
| $525K | 0.4% | 6,240 | – | – |
|
44
Meta Platforms (Facebook)
META
$1.86T
| $481K | 0.37% | 2,700 -16,100 | -86% | -$2.87M |
|
45
BP
BP
$90.8B
| $476K | 0.37% | 12,532 | – | – |
|
46
Adobe
ADBE
$151B
| $470K | 0.36% | +1,700 | New | +$470K |
|
|
RDS.B
47
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $467K | 0.36% | 7,792 | – | – |
|
48
CRISPR Therapeutics
CRSP
$4.71B
| $410K | 0.31% | 10,000 | – | – |
|
49
TherapeuticsMD
TXMD
$12.8M
| $407K | 0.31% | 112,000 | – | – |
|
50
Editas Medicine
EDIT
$231M
| $341K | 0.26% | 15,000 | – | – |
|